symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
EOLS,8.48,1.640457,561373,482705344,0,6.51-11.49,0.18,"Evolus, Inc.",USD,0001570562,US30052C1071,30052C107,NASDAQ Global Market,NASDAQ,Drug Manufacturersâ€”Specialty & Generic,https://www.evolus.com,"Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.",Mr. David  Moatazedi,Healthcare,US,215,949 284 4555,520 Newport Center Drive,Newport Beach,CA,92660,0.468454,10.7185,https://financialmodelingprep.com/image-stock/EOLS.png,2018-02-08,False,False,True,False,False
